Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Profound intellectual disability, Brain shrinkage (cerebral atrophy), Absent speech, and Loss of previously acquired skills (developmental regression) and others; and very common findings: Inability to walk and Spasticity. 27 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 18 | Inability to walk, Dystonia, Cerebral cortical atrophy |
UBTF function has not been fully characterized.
Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder is caused by mutations in the UBTF gene on chromosome 17.
Genetic testing for UBTF is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 2 very common features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE1. Research is primarily sponsored by academic and government institutions.
111 publications have been identified in PubMed for childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder. Research spans Review / Meta-Analysis (32%), Basic Science / Preclinical (23%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 35 |
Data assembled from 8 of 12 sources · Last updated Sep 20, 2026, 9:35 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder
Muscles | 3 | Shrinkage of the cerebellum (cerebellar atrophy), Cerebral cortical atrophy, Brain shrinkage (cerebral atrophy) |
Digestive system | 2 | Difficulty swallowing (dysphagia), Feeding difficulties |
Head and neck | 1 | Secondary microcephaly |
Laboratory research | 25 | 23% |
Disease patterns and progression | 18 | 16% |
Patient case studies | 16 | 14% |
New treatment approaches | 8 | 7% |
Testing and diagnosis research | 4 | 4% |
Clinical study results | 3 | 3% |
Other research | 2 | 2% |
Roy S (2026). [PMID: 41535061](https://pubmed.ncbi.nlm.nih.gov/41535061/). *BMJ Case Rep*. [Case Report / Case Series]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Epidemiology / Natural History]
Lázár E (2026). [PMID: 41028908](https://pubmed.ncbi.nlm.nih.gov/41028908/). *Nature reviews. Genetics*. [Review / Meta-Analysis]
Sartorelli J (2026). [PMID: 41833177](https://pubmed.ncbi.nlm.nih.gov/41833177/). *Mol Genet Metab*. [Epidemiology / Natural History]
David C (2026). [PMID: 41395910](https://pubmed.ncbi.nlm.nih.gov/41395910/). *Annals of the rheumatic diseases*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *American journal of human genetics*. [Basic Science / Preclinical]
Yi S (2026). [PMID: 41534641](https://pubmed.ncbi.nlm.nih.gov/41534641/). *Clin Chim Acta*. [Case Report / Case Series]
Hernández-Pérez C (2026). [PMID: 41683572](https://pubmed.ncbi.nlm.nih.gov/41683572/). *Int J Mol Sci*. [Basic Science / Preclinical]
Lynch M (2026). [PMID: 41767121](https://pubmed.ncbi.nlm.nih.gov/41767121/). *JIMD Rep*. [Diagnostic / Biomarker]
Park HE (2025). [PMID: 40323519](https://pubmed.ncbi.nlm.nih.gov/40323519/). *Japanese journal of ophthalmology*. [Case Report / Case Series]